Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
ALS—Could Stability Rather than Activity of SOD Hold the Key?
24 December 2002. Over 100 point mutations in the Cu/Zn superoxide dismutase (SOD) gene have been linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Exactly why these mutations cause ALS is unclear, but abounding explanations fall into two main camps-those that hinge on mutants being catalytically active, and those that do not. A report in today's PNAS from researchers at Umea University, Sweden, strongly supports the latter view.

Senior author Mikael Oliveberg and colleagues characterized ALS-associated SOD mutants containing single amino-acid substitutions in various parts of the protein. The authors found that one thing all mutants had in common is that their apo protein, i.e., the protein alone without its active-site metal ions, is less stable than wild-type apo protein. First author Mikael Lindberg et al. determined this by denaturing the proteins with either guanidium chloride or urea.

The authors found that substituting alanine for glycine at position 93, for example, resulted in complete denaturation of the polypeptide at a concentration of two molar urea, whereas four molar is needed to denature wild-type apo protein. Mutating N-terminal amino acids (valine for alanine at position 4, and phenylalanine for cysteine at postion 6), which are buried in the hydrophobic core of the protein, had even more drastic effects. Interestingly, substituting alanine for cysteine at position 6, a mutation that is not associated with ALS but is found in other, presumably healthy organisms, has no effect on the stability of the apo protein.

The results suggest that destabilization of the immature protein may be a contributing factor to ALS progression. This supports recent data indicating that copper loading of SOD is not required for manifestation of the disease (see related new item). It is also noteworthy that the least stable mutants (i.e., A4V, and C6F) are also associated with faster progression of ALS.-Tom Fagan.

Reference:
Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state. PNAS 2002 December 24;99:16607-16612. Abstract

See related news story.

 
Comments on News and Primary Papers
  Comment by:  Tennore Ramesh
Submitted 4 December 2002  |  Permalink Posted 4 December 2002

First of all I must admit that I am not an expert on the dynamics of SOD protein folding. In this paper, Lindberg et al. provide data that suggests the involvement of Apo-SOD in ALS disease pathogenesis. It has been known for a long time that the development of the disease in familial SOD1 mutation is not dependent on SOD enzymatic activity and the mutation is a dominant gain of function. Alterations in expression of wild-type SOD enzyme by over-expression or targeted deletion of SOD show no effect on the disease course of mutant SOD1 mice. More recently it was shown that substantial reduction in copper binding activity by deletion of CCS does not alter disease course in the SOD1 mice (see ARF related news story), suggesting again that SOD enzymatic activity may not be involved in the disease process. This paper supports these earlier observations and lends more credence to the idea that SOD1 mutation causes a protein conformation disease. The generation of high molecular weight isoforms of SOD, SOD1 inclusions and...  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad